Specific interactions of monotetrahydrofuranic annonaceous acetogenins as inhibitors of mitochondrial complex I

被引:57
作者
Tormo, JR
Gallardo, T
Aragón, R
Cortes, D
Estornell, E
机构
[1] Univ Valencia, Fac Farm, Dept Bioquim & Biol Mol, E-46100 Valencia, Spain
[2] Univ Valencia, Fac Farm, Dept Farmacol, E-46100 Valencia, Spain
[3] Univ Valle, Dept Quim, Cali, Colombia
关键词
Annonaceous acetogenin; antitumor drug; mitochondrial complex I; respiratory chain inhibitor;
D O I
10.1016/S0009-2797(99)00120-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Annonaceous acetogenins (ACG) are a wide group of cytotoxic compounds isolated from plants of the Annonaceae family. Some of them are promising candidates to be a future new generation of antitumor drugs due to the ability to inhibit the NADH:ubiquinone oxidoreductase of the respiratory chain (mitochondrial complex I), main gate of the energy production in the cell. ACG are currently being tested on standard antitumor trials although little is known about the structure-activity relationship at the molecular level. On recent studies, the relevance of several parts of the molecule for the inhibitory potency has been evaluated. Due to the great diversity of skeletons included in this family of natural products, previous studies on the presence and distribution of oxygenated groups along the alkyl chain only covered the compounds with different bis-tetrahydrofuranic (bis-THF) relative configurations. Therefore, we have investigated the inhibitory action of all the mono-tetrahydrofuranic (mono-THF) acetogenins available, which differ in the oxygenated arrangements along the molecule. Our results show that the hydroxyl and carbonyl groups, placed in the aliphatic chain that links the initial gamma-lactone moiety with the dihydroxylated tetrahydrofuranic ring system, significantly contribute for modulating the inhibitory potency of the ACG through specific effects. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:171 / 183
页数:13
相关论文
共 34 条
[1]  
Alfonso Dorothee, 1996, Natural Toxins, V4, P181, DOI 10.1002/19960404NT6
[2]   Enantiospecific semisynthesis of (+)-almuheptolide-A, a novel natural heptolide inhibitor of the mammalian mitochondrial respiratory chain [J].
Bermejo, A ;
Tormo, JR ;
Cabedo, N ;
Estornell, E ;
Figadere, B ;
Cortes, D .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (26) :5158-5166
[3]   Proton-translocation by membrane-bound NADH:ubiquinone-oxidoreductase (complex I) through redox-gated ligand conduction [J].
Brandt, U .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1997, 1318 (1-2) :79-91
[4]  
CAVE A, 1997, PROGR CHEM ORGANIC N, V70, P21
[5]   A reductant-induced oxidation mechanism for Complex I [J].
Dutton, PL ;
Moser, CC ;
Sled, VD ;
Daldal, F ;
Ohnishi, T .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1998, 1364 (02) :245-257
[6]   Inhibitors of NADH-ubiquinone reductase: an overview [J].
Esposti, MD .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1998, 1364 (02) :222-235
[7]   NATURAL SUBSTANCES (ACETOGENINS) FROM THE FAMILY ANNONACEAE ARE POWERFUL INHIBITORS OF MITOCHONDRIAL NADH DEHYDROGENASE (COMPLEX-I) [J].
ESPOSTI, MD ;
GHELLI, A ;
RATTA, M ;
CORTES, D ;
ESTORNELL, E .
BIOCHEMICAL JOURNAL, 1994, 301 :161-167
[8]   THE MECHANISM OF PROTON AND ELECTRON-TRANSPORT IN MITOCHONDRIAL COMPLEX-I [J].
ESPOSTI, MD ;
GHELLI, A .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1994, 1187 (02) :116-120
[9]   The specificity of mitochondrial complex I for ubiquinones [J].
Esposti, MD ;
Ngo, A ;
McMullen, GL ;
Ghelli, A ;
Sparla, F ;
Benelli, B ;
Ratta, M ;
Linnane, AW .
BIOCHEMICAL JOURNAL, 1996, 313 :327-334
[10]   COMPLEX-I AND COMPLEX-III OF MITOCHONDRIA HAVE COMMON INHIBITORS ACTING AS UBIQUINONE ANTAGONISTS [J].
ESPOSTI, MD ;
GHELLI, A ;
CRIMI, M ;
ESTORNELL, E ;
FATO, R ;
LENAZ, G .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 190 (03) :1090-1096